1,038
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Does therapeutic plasma exchange have a role in resistant cytokine storm state of COVID-19 infection?

ORCID Icon, , ORCID Icon, , &
Pages 235-239 | Received 02 Jul 2021, Accepted 24 Sep 2021, Published online: 03 Nov 2021

References

  • Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.
  • WHO. Coronavirus disease 2019 (COVID-19) Situation Report 52; 2020.
  • WHO. Coronavirus disease 2019 (COVID-19) Weekly epidemiological update; 2020 December 29.
  • Chan J, Yuan S, Kok K, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person to-person transmission: a study of a family cluster. Lancet. 2020;395:514–523.
  • Ruan Q, Yang K, Wang W, et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46(5):846–848.
  • Chen G, Wu D, Guo W, et al. Clinical and immunologic features in severe and moderate coronavirus disease 2019. J Clin Invest. 2020;130(5):2620–2629.
  • Ragab D, Salah Eldin H, Taeimah M, et al. COVID-19 cytokine storm; what we know so far. Front Immunol. 2020;11:1446.
  • Ye Q, Wang B, Mao J. The pathogenesis and treatment of the ‘cytokine storm’ in COVID-19. J Infect. 2020;80(6):607–613.
  • Patel P, Nandwani V, Vanchiere J, et al. Use of therapeutic plasma exchange as a rescue therapy in 2009 pH1N1 influenza A–an associated respiratory failure and hemodynamic shock. Pediatr Crit Care Med. 2011;12(2):e87–9.
  • Masoud H, Elassal G, Hassany M, et al. Management Protocol for COVID-19 Patients MoHP Protocol for COVID19 November 2020; 2020.
  • Diao B, Wang C, Tan Y, et al. Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19). Front Immunol. 2020;11:827.
  • Gluck WL, Gallahan SP, Breevetta RA, et al. Efficacy of therapeutic plasma exchange in the treatment of Penn class 3 and 4 cytokine release syndrome complicating COVID-19. Resp Med. 2020;175:106188.
  • Adeli SH, Ashgari A, Tabarraii R, et al. Therapeutic plasma exchange as a rescue therapy in patients with corona virus disease 2019: a case series. Pol Arch Intern Med. 2020;130(5):455–458.
  • Zhang L, Zhai H, Ma S, et al. Efficacy of therapeutic plasma exchange in severe COVID 19 patients. Br J Haematol. 2020;190(4):181–183.
  • Sarfraz A, Makkar SS, Sarfraz Z, et al. Therapeutic plasma exchange and COVID 19: a rapid review. J Clin Immunol Immunother. 2020;6:041.
  • Shi H, Zhou C, He P, et al. Successful treatment with plasma exchange followed by intravenous immunoglobulin in a critically ill patient with COVID-19. Int J Antimicrob Agents. 2020;56(2):105974.
  • Khamis F, Al-Zakwani I, Al Hashmi S, et al. Therapeutic plasma exchange in adults with severe COVID 19 infection. Int J of Infect Dis. 2020;99:214–218.
  • Keith P, Day M, Perkins L, et al. A novel treatment approach to the novel coronavirus: an argument for the use of therapeutic plasma exchange for fulminant COVID-19. Crit Care. 2020;24(1):128.